drugset / Trial / NCT01946815

Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

NCT01946815 ↗

NaSingle-groupOpen-labelTreatment

Summary

Natural course of intermediate coronary artery disease (CAD) is very important to predict the prognosis of the patient with such disease. Several studies have well demonstrated the beneficial effect of lipid-lowering therapy on the progression of CAD with the modification of lipid profiles. This effect can be also explained by intravascular ultrasound (IVUS) or optical coherence tomography. However, the effect of plaque modification on coronary physiology has been rarely evaluated. This research is to evaluate the change of intermediate or nonculprit coronary lesion on lipid-lowering therapy via IVUS(optional) and FFR.

Timeline

Start
2013-09
Primary completion
2018-11
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg —
Subject Atorvastatin Small molecule 40 mg —
Subject Atorvastatin Small molecule 80 mg —